EU Approves Novo Nordisk’s Frehemgo for Hemophilia A
Novo Nordisk said the European Commission approved Frehemgo for routine prophylaxis to prevent or reduce bleeding episodes in patients with hemophilia A.
By Mauro OrruNovo Nordisk said it had received approval from the European Union to sell its Frehemgo drug as a routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.The Danish drugmaker said the European Commission, the EU's executive arm, had gra…